Maria-Luiza Hiceag

Dr. Maria-Luiza Hiceag


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CCCorina Cinezan
Corina Cinezan
DMDan Claudiu Măgureanu
Dan Claudiu Măgureanu
MHMaria-Luiza Hiceag
Maria-Luiza Hiceag
CRCamelia Bianca Rus
Camelia Bianca Rus
TITiberia Ilias
Tiberia Ilias
ACAngela Cozma
Angela Cozma
Aortic stenosis (AS) and atherosclerosis are progressive cardiovascular conditions that frequently coexist and share multiple clinical and molecular features. Medical therapies have shown effectiveness in preventing and treating atherosclerosis and its consequences. For AS, effective pharmacological therapies remain limited. Understanding the shared risk factors and mechanisms between the two conditions may provide opportunities for therapeutic repositioning in AS. We performed a narrative review focusing on studies published from 2005 to 2025. Inclusion criteria encompassed clinical trials, experimental models, and molecular studies addressing overlapping risk factors, pathological pathways, and treatment approaches for AS and atherosclerosis. AS and atherosclerosis share key risk factors, including age, hypertension, hyperlipidemia, and diabetes. Molecular mechanisms, such as chronic inflammation, endothelial dysfunction, oxidative stress, lipid accumulation, and calcific remodeling, are common to both. Pathways involving the renin-angiotensin system, Notch signaling, and osteogenic mediators contribute to disease progression. Several drug classes, notably proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, lipoprotein(a) (Lp(a)) lowering therapies, anti-inflammatory agents, and immunomodulators, show potential for repositioning in AS management. The substantial overlap in risk factors and molecular mechanisms between AS and atherosclerosis supports a rationale for therapeutic repositioning. Targeting shared pathways could lead to innovative strategies for slowing AS progression and improving patient outcomes.

25 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DMDan Claudiu Măgureanu
Dan Claudiu Măgureanu
MHMaria-Luiza Hiceag
Maria-Luiza Hiceag
CRCamelia Bianca Rus
Camelia Bianca Rus
TGTIMEA CLAUDIA GHITEA
TIMEA CLAUDIA GHITEA
CCCorina Cinezan
Corina Cinezan
Background/Objectives: Inflammation plays a central role in the pathophysiology of ST-elevation myocardial infarction (STEMI) and may influence myocardial injury, ventricular dysfunction and clinical outcomes. Simple inflammatory biomarkers derived from routine laboratory tests have been proposed as potential prognostic indicators in patients undergoing primary percutaneous coronary intervention (PCI). Objective: This study aimed to evaluate the association between admission inflammatory biomarkers, echocardiographic markers of ventricular dysfunction and in-hospital mortality in patients with STEMI treated with primary PCI. Methods: We conducted a retrospective observational study including 600 consecutive patients admitted with STEMI and treated with primary PCI between January 2021 and August 2025. Inflammatory biomarkers measured at admission included C-reactive protein (CRP); neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte ratio (PLR); systemic immune-inflammation index (SII) and C-reactive protein-to-lymphocyte ratio (CLR). Echocardiographic parameters and clinical outcomes were recorded. Multivariable logistic regression analysis was performed to identify independent predictors of in-hospital mortality. Results: In-hospital mortality occurred in 54 patients (9.0%). Patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) had significantly higher CRP and CLR levels (p < 0.01). Inflammatory biomarkers were associated with markers of ventricular dysfunction but were not independent predictors of mortality. Age, LVEF < 40% and the number of residual coronary lesions independently predicted in-hospital death. Conclusions: In STEMI patients undergoing primary PCI, early mortality is mainly determined by age; ventricular dysfunction and residual coronary disease burden, while inflammatory biomarkers primarily reflect the severity of myocardial injury rather than independently predicting short-term mortality.

19 October 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CCCorina Cinezan
Corina Cinezan
Alexandra BuzleAlexandra Buzle
Alexandra Buzle
MHMaria-Luiza Hiceag
Maria-Luiza Hiceag
CRCamelia Bianca Rus
Camelia Bianca Rus
Background: Electrocardiographic (ECG) abnormalities are common in acute pulmonary embolism (PE), but the prognostic significance of P wave morphology remains unclear. Early identification of high-risk patients is critical for guiding therapy and monitoring. Methods: We retrospectively analyzed 300 patients with confirmed PE. P wave morphology (normal, biphasic, notched, peaked) was evaluated for association with in-hospital mortality using chi-square and logistic regression, adjusted for age, sex, PESI score, and oxygen saturation. Results: Mortality differed significantly across P wave groups (χ2 = 35.3, df = 3, p < 0.001). In univariate analysis, biphasic (OR 15.38, 95% CI 5.02–47.10, p < 0.001) and peaked (OR 7.21, 95% CI 2.35–22.10, p = 0.001) morphologies were strongly associated with mortality, whereas notched P waves were not (OR 1.44, 95% CI 0.16–12.87, p = 0.743). After adjustment, biphasic (OR 14.87, 95% CI 4.77–46.37, p < 0.001) and peaked (OR 6.58, 95% CI 2.11–20.53, p = 0.001) shapes remained independent predictors. Age, sex, PESI score, and oxygen saturation were not significant in multivariable analysis. Conclusions: Biphasic and peaked P wave morphologies on ECG are strong predictors of in-hospital mortality in patients with PE. Routine assessment of P wave shape may provide a simple tool for early risk stratification, warranting validation in prospective cohorts.

Verified
Journal Article
Open access
PDF file
CCCorina Cinezan
Corina Cinezan
MHMaria-Luiza Hiceag
Maria-Luiza Hiceag
Background: The extent of coronary artery disease (CAD) is a major determinant of prognosis in patients with myocardial infarction (MI). While structured exercise is known to be cardioprotective, the association between habitual daily physical activity and angiographic CAD extension remains insufficiently characterized. Methods: In this prospective observational study, 269 patients were hospitalized with acute MI underwent coronary angiography. Habitual daily physical activity during the four weeks preceding admission was assessed using 10-point self-reported daily preadmission effort questions to help the patients to report a final effort score. CAD extension was classified as single-, double- or triple-vessel disease. Differences in daily effort across CAD categories were evaluated using the Kruskal–Wallis test. Independent predictors of CAD extension were identified using ordinal logistic regression adjusted for age, sex, smoking, hypertension, diabetes mellitus, hyperlipidemia and body mass index. Results: Daily preadmission effort decreased progressively with increasing CAD severity (mean scores: 7.44 in single-vessel, 4.93 in double-vessel and 3.69 in triple-vessel disease; p < 0.0001). In multivariable ordinal logistic regression analysis, older age, hypertension, diabetes mellitus and hyperlipidemia were independently associated with greater CAD extension. Higher daily preadmission effort was strongly and independently associated with lower CAD severity; each one-point increase in effort score was associated with a 46% reduction in the odds of more extensive CAD (odds ratio 0.54, 95% confidence interval 0.45–0.64; p < 0.0001). Conclusions: Greater habitual daily physical activity prior to myocardial infarction is independently associated with less extensive coronary artery disease. Assessment of daily preadmission effort may provide clinically useful information regarding coronary disease burden and highlights the potential importance of everyday physical activity in cardiovascular prevention. These findings should be interpreted with caution given the use of a non-validated, self-reported measure of physical activity and the observational study design.

7 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DMDan Claudiu Măgureanu
Dan Claudiu Măgureanu
MHMaria-Luiza Hiceag
Maria-Luiza Hiceag
CRCamelia Bianca Rus
Camelia Bianca Rus
TGTIMEA CLAUDIA GHITEA
TIMEA CLAUDIA GHITEA
CCCorina Cinezan
Corina Cinezan
We sincerely thank the author for the thoughtful and constructive comment highlighting the potential complementary role of cellular stress markers in the prognostic assessment of patients with ST-segment elevation myocardial infarction (STEMI)